Tag: Potentially

Scientists have identified a drug that can prevent the virus that causes COVID-19 from binding to human cells, potentially preventing damage to the lung, clot formation and the development of sepsis. The study, led by researchers from RCSI University of Medicine and Health Sciences, is published in PLOS ONE. The researchers identified that a mutation,

The heart’s ability to beat normally over a lifetime is predicated on the synchronized work of proteins embedded in the cells of the heart muscle. Like a fleet of molecular motors that get turned on and off, these proteins cause the heart cells to contract, then force them to relax, beat after life-sustaining beat. Now

Mother, 32, escapes death after she caught a potentially killer bug Mother, 32, narrowly escapes death after doctors TWICE failed to spot she had caught a dangerous stomach bug which had triggered the silent killer sepsis Rosie Summers unknowingly caught Clostridium difficile while in hospital The bug led to sepsis – a violent and deadly

Research from the University of Warwick indicates that taking a tablet a day can help treat cancer patients of a potentially deadly condition. People with cancer have an increased risk of developing blood clots, with roughly one in five experiencing venous thromboembolism (VTE) – either deep vein thrombosis (DVT) or pulmonary embolism (PE). Blood clots

Researchers have discovered a new family of substances which has been found to display highly potent activity against the release of pro-inflammatory cytokines and the toxicity induced by reactive oxygen species (ROS). The novel compounds synthesized and evaluated belong to a family of low molecular weight substances named indolines. In early experiments, these compounds have

(HealthDay)—Potentially inappropriate medication (PIM) use is relatively prevalent among patients with breast or colorectal cancer, though it is not associated with most adverse outcomes, according to a study published online April 24 in Cancer. Meghan S. Karturi, M.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues examined the impact of